OTC · SGBI
Sangui Biotech International, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Aug 23, 2026, 5:48 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 41.98K
- P/E ratio
- 0.41
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 200K
- Avg. volume
- 113.56K
Price performance
SGBI price history
1M range · 0 trading sessions · Daily adjusted prices
SGBI does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest SGBI news
The latest Smart Investors Daily articles mentioning SGBI.
Stock researchCompany · Overview
SGBI research
Overview
Company profile and research snapshot.
Company profile
Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
